About Kredenz Pharma Private Limited
Data last updated:
Kredenz Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 25 May 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24290TG2016PTC109885.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Madhukar Vempalla and Parthasarathy Rajagopalan.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No. B – 10/C Ida Moula – Ali, Hyderabad, Telangana, India – 500040.
As per the financials filed for FY 2025, the company reported a revenue of ₹10.97 Lakh, a growth of 40% compared to the previous year. For the same year it recorded a net profit of ₹1.25 Lakh (net margin 11.4%) and EBITDA of ₹1.49 Lakh (EBITDA margin 13.6%).
The company is associated with 1 brand: Kredenz Pharma.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website kredenzpharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressPlot No. B – 10/C Ida Moula – Ali, Hyderabad, Telangana, India – 500040
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Associated Brands with Kredenz Pharma Private Limited
Kredenz Pharma operates one associated brand: Kredenz Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures active pharmaceutical ingredients and intermediates for the industry. | kredenzpharma.com |
Business Activity of Kredenz Pharma Private Limited
The main business activity of Kredenz Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Kredenz Pharma Private Limited FY 2025 filings available
Kredenz Pharma Private Limited reported revenue of ₹10.97 Lakh (up 40% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Kredenz Pharma Private Limited
Revenue rose 40% in the latest year. EBITDA rose 10% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Kredenz Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹1.49 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1.25 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Kredenz Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 13.6% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 11.4% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Kredenz Pharma are in the company report.
Financial statements from FY 2017
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Kredenz Pharma Private Limited
Kredenz Pharma has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Madhukar Vempalla Also directs: Plasma Organics Private Limited, SM Labs Private Limited | Director | 25 May 2016 | 10 Years 4 Months | Current |
| Parthasarathy Rajagopalan | Director | 25 May 2016 | 10 Years 4 Months | Current |
| Jagan Mohan Reddy Narsa Reddy | Director | 25 May 2016 | 10 Years 4 Months | Current |
Peer Comparison of Kredenz Pharma Private Limited
Kredenz Pharma Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Armor Lifecare Private Limited | ₹11.1 Lakh (FY 2025) | •••• | •••• | 34.0% | •••• | Kashipur, Uttarakhand, India |
| Green Era Agri World Private Limited | ₹11.06 Lakh (FY 2025) | •••• | •••• | -47.0% | •••• | Pune, Maharashtra, India |
| Panorbis Lifesciences Private Limited | ₹11.03 Lakh (FY 2020) | •••• | •••• | -50.0% | •••• | Nagpur, Maharashtra, India |
| Siddhi Ceracolours Private Limited | ₹11.02 Lakh (FY 2024) | •••• | •••• | 40.0% | •••• | Morbi, Gujarat, India |
| Jonakayem Pharma - Formulation OPC Private Limited | ₹10.99 Lakh (FY 2023) | •••• | •••• | -73.0% | •••• | Mumbai, Maharashtra, India |
| Kredenz Pharma Private Limited this company | ₹10.97 Lakh (FY 2025) | •••• | •••• | 40.0% | •••• | Hyderabad, Telangana, India |
| Biokain Pharmaceutical Private Limited | ₹10.97 Lakh (FY 2025) | •••• | •••• | 142.0% | •••• | Hyderabad, Telangana, India |
| Truth Biotech Private Limited | ₹10.95 Lakh (FY 2025) | •••• | •••• | 297.0% | •••• | Berhampur, Odisha, India |
| Erinus Healthcare Private Limited | ₹10.95 Lakh (FY 2024) | •••• | •••• | 90.0% | •••• | New Delhi, Delhi, India |
| Brykonchem India Private Limited | ₹10.94 Lakh (FY 2024) | •••• | •••• | 1786.0% | •••• | Pune, Maharashtra, India |
| Glyzy Technologies Private Limited | ₹10.94 Lakh (FY 2025) | •••• | •••• | -9.0% | •••• | Bangalore, Karnataka, India |
Peers are the five companies nearest above and the five nearest below Kredenz Pharma by revenue in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Kredenz Pharma Private Limited
Kredenz Pharma Private Limited is audited by VIJAY CHANDRA & ASSOCIATES for the financial year 2017.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| VIJAY CHANDRA & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Kredenz Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Kredenz Pharma Private Limited
Kredenz Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Kredenz Pharma Private Limited
Employment history and EPFO contributions of people linked to Kredenz Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Kredenz Pharma Private Limited
Kredenz Pharma Private Limited has 3 board changes on record since 2016: 3 appointments. The latest: Jagan Mohan Reddy Narsa Reddy was appointed as Director on 25 May 2016.
Credit Ratings, Litigation & Regulatory Alerts for Kredenz Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Kredenz Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Kredenz Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Kredenz Pharma Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Kredenz Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kredenz Pharma Private Limited
Kredenz Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 25 May 2016 (10+ years old) and is registered under CIN U24290TG2016PTC109885.
Kredenz Pharma reported revenue of ₹10.97 Lakh for FY 2025 (up 40% YoY).
Kredenz Pharma has 3 current directors:
- Madhukar Vempalla - Director
- Parthasarathy Rajagopalan - Director
- Jagan Mohan Reddy Narsa Reddy - Director
Kredenz Pharma reported a net profit of ₹1.25 Lakh (net margin 11.4%) and EBITDA of ₹1.49 Lakh (EBITDA margin 13.6%) for FY 2025, as per its filed financial statements.
The CIN (Corporate Identification Number) of Kredenz Pharma is U24290TG2016PTC109885. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Kredenz Pharma was incorporated on 25 May 2016, making it 10+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Kredenz Pharma by revenue are Armor Lifecare Private Limited, Green Era Agri World Private Limited, Panorbis Lifesciences Private Limited, Siddhi Ceracolours Private Limited, Jonakayem Pharma - Formulation OPC Private Limited and 5 more, all in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Jagan Mohan Reddy Narsa Reddy was appointed as Director on 25 May 2016. Madhukar Vempalla was appointed as Director on 25 May 2016. Parthasarathy Rajagopalan was appointed as Director on 25 May 2016.
Kredenz Pharma can be reached through the website kredenzpharma.com. Its registered office is in Hyderabad, Telangana, India.
The registered office of Kredenz Pharma is at Plot No. B – 10C Ida Moula – Ali, Hyderabad, Telangana, India – 500040.
Kredenz Pharma has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh.